International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
Titel:
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
Auteur:
Novello, S. Torri, V. Grohe, C. Kurz, S. Serke, M. Wehler, T. Meyer, A. Ladage, D. Geissler, M. Colantonio, I. Cauchi, C. Stoelben, E. Ceribelli, A. Kropf-Sanchen, C. Valmadre, G. Borra, G. Schena, M. Morabito, A. Santo, A. Gregorc, V. Chiari, R. Reck, M. Schmid-Bindert, G. Folprecht, G. Griesinger, F. Follador, A. Pedrazzoli, P. Bearz, A. Caffo, O. Dickgreber, N.J. Irtelli, L. Wiest, G. Monica, V. Porcu, L. Manegold, C. Scagliotti, G.V.